Načítá se...
Intravitreal bevacizumab and ranibizumab injections for patients with polypoidal choroidal vasculopathy
PURPOSE: To compare the effectiveness of intravitreal injection of bevacizumab and ranibizumab in patients with treatment-naïve polypoidal choroidal vasculopathy (PCV). METHODS: A total of 66 and 60 eyes of 121 consecutive patients who received intravitreal bevacizumab (1.25 mg) or ranibizumab (0.5 ...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3298981/ https://ncbi.nlm.nih.gov/pubmed/22173075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2011.324 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|